Cell line · CVCL_0334
Hs 766T
Cancer cell line, Homo sapiens. Pancreatic adenocarcinoma. 44 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. Hs 766T. Cell lines, record CVCL_0334. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0334
On this page
Cell line
As Cellosaurus gives it.
- Name
- Hs 766T
- Accession
- CVCL_0334
- RRID
- RRID:CVCL_0334
- Synonyms
- Hs 766.T, HS-766T, Hs-766T, HS 766T, HS-766-T, Hs-766-T, HS766T, Hs766T, H766T, 766T, Hs 766
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 64Y
- Category
- Cancer cell line
- Diseases
- Pancreatic adenocarcinoma (NCIt C8294)
- Derived from
- Lymph node (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems3
| Problem | Cellosaurus's note |
|---|---|
| Caution | Indicated as originating from a 46 year old male patient in ATCC and from a 64 year old male patient in PubMed=283258 and PubMed=761205. |
| Caution | Incorrectly reported to have no KRAS mutation in PubMed=8026879 and PubMed=15367885. |
| Caution | TP53 mutation indicated incorrectly as being at c.542G>A in PubMed=1630814. |
Source Cellosaurus
Papers44
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Targeting SERPINB5 and MSLN for Pancreatic Cancer Therapy. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| KLF5 enables dichotomous lineage programs in pancreatic cancer via the AAA+ ATPase coactivators RUVBL1 and RUVBL2. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Defining the Antitumor Mechanism of Action of a Clinical-stage Compound as a Selective Degrader of the Nuclear Pore Complex. | Cancer Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations. | Cancer Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic Cancer. | Int J Mol Sci | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases. | Cell Rep Med | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression. | Dig Dis Sci | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Non-canonical functions of SNAIL drive context-specific cancer progression. | Nat Commun | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Functional and biological heterogeneity of KRASQ61 mutations. | Sci Signal | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed |
1 to 10 of 44
See all 44 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | 1.A16 | CVCL_E4F6 | Cell lines | |
| Derived from it | 1.A18 | CVCL_E4F7 | Cell lines | |
| Derived from it | 1.A21 | CVCL_E4F8 | Cell lines | |
| Derived from it | 1.B6 | CVCL_E4F9 | Cell lines | |
| Derived from it | 2.B2 | CVCL_E4FA | Cell lines |
Cell banks1
| Cell bank | Catalog number | Status |
|---|---|---|
| ATCC | HTB-134 |
Source ATCC
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0334
GET https://conductscience.org/api/cell-lines/v1/CVCL_0334/papers?page=2